A centralised, mailed colorectal cancer screening programme significantly improved screening completion rates in federally qualified health centres. Read more.
New data reveals that longer-term lebrikizumab treatment significantly improves outcomes for patients with moderate-to-severe atopic dermatitis who didn’t meet response criteria by week 16.